Collaborator Wuhan HealthCare Biotechnology
FISH-Sondenreagenz\RUO\\Catalogue image available\\Specification fields populated\
ABM46364

ETV4 Break Apart FISH Sondenreagenz

ABMIUM Verified™|RUO|FISH-Sonde|Wuhan HealthCare Biotechnology|ISO 13485|ISO 9001

ETV4 Break Apart FISH-Sondenreagenz von Wuhan HealthCare Biotechnology Read more ›

ETV4 Break Apart FISH Probe Reagent catalogue image
Zoom
ETV4 Break Apart FISH Probe Reagent catalogue image

Product Description

This reagent supports fluorescence in situ hybridisation analysis of ETV4, using a break-apart probe design for rearrangement-focused workflows. Probe design: Break-apart. Sample scope: Prepared FISH slide. Pack format: 100µL/kit; 10 tests.

Key Facts

Product typeFISH-Sondenreagenz Target: ETV4
Collaborator Wuhan HealthCare Biotechnology
Partner model FP-116
Target ETV4
Research areasCytogenetics, oncology, molecular pathology research
Applications FISCH
Assay type Fluoreszenz-in-situ-Hybridisierung (FISH)
Sample types Präparierter FISH-Objektträger
Detection range N/A
Sensitivity N/A
Shelf life 12 Monate bei lichtgeschützter Lagerung in verschlossenen Gebinden bei -20°C ±5°C
AvailabilityJetzt bestellen
Lead time3 to 5 days
Why ABMIUM?
2,000+ Researchers trust us
50,000+ Citations
ISO 9001 Certified Collaborators
Independently handpicked Products selected for quality and fit

Spezifikationen

Target
ETV4
Also known as
ETV4|ETV4 (17q21) gene break apart probe reagent
Form / buffer
Sondierreagenz

Lagerung und Stabilität

Storage conditions
Versiegelt und lichtgeschützt bei –20 °C ±5 °C lagern. Wiederholtes Einfrieren und Auftauen vermeiden.
Shelf life
12 Monate bei lichtgeschützter Lagerung in verschlossenen Gebinden bei -20°C ±5°C

Compliance & Zertifizierungen

ABMIUM
ABMIUM Verified

Collaborator meets ABMIUM quality standards and overall product performance standards have been met.

ISO
ISO 13485|ISO 9001

Quality management certification.

RUO
Research Use Only

For research applications. Not for diagnostic use.

Kundenbewertungen

No customer reviews yet.